The Biologics News and Reports Portal

Show Cart

Therapeutic Proteins & Peptides

Results 11 - 19 of 19

Jul 2014 Competitor Analysis: alpha1-Proteinase Inhibitors (alpha1-PI), alpha1-Antitrypsin (AAT) and Elastase Inhibitors

200.00 €

Jun 2013 Recombinant Coagulation Factors 2013 – The Race to Market and for Market Shares

2,150.00 €

May 2013 Competitor Analysis: Coagulation Factors

600.00 €

Feb 2013 Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

250.00 €

Jan 2013 Competitor Analysis: Enzyme Replacement Therapies

300.00 €

Mar 2012 Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012

1,950.00 €

Oct 2011 Coagulation Factors 2011 – who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis

1,920.00 €

2,400.00 €

(Discount: 20.00%)

Sep 2010 Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins

2,495.00 €

Aug 2009 Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis

2,450.00 €

Start
Prev
1
2
Next
End

Shopping cart

Cart empty

Shopping cart

Cart empty

Latest report

CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing

Featured Products

2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Latest Target Pipeline

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

Therapeutic Proteins & Peptides

Jul 2014 Competitor Analysis: alpha1-Proteinase Inhibitors (alpha1-PI), alpha1-Antitrypsin (AAT) and Elastase Inhibitors

Jun 2013 Recombinant Coagulation Factors 2013 – The Race to Market and for Market Shares

May 2013 Competitor Analysis: Coagulation Factors

Feb 2013 Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

Jan 2013 Competitor Analysis: Enzyme Replacement Therapies

Mar 2012 Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012

Oct 2011 Coagulation Factors 2011 – who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis

Sep 2010 Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins

Aug 2009 Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing